MedPath
NMPA Approval

Moxifloxacin Hydrochloride Tablets

国药准字HJ20210032

Hexal AG

May 19, 2021

Drug Information

盐酸莫西沙星片

片剂

0.4g(按C21H24FN3O4计)

化学药品

May 19, 2021

May 18, 2026

Company Information

Applicant Company

Hexal AG

Industriestraβe 25, 83607 Holzkirchen, Germany

Manufacturing Company

s.c. sandoz s.r.l.

Str. Livezeni nr. 7A, 540472 TARGU-MURES, Romania

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

盐酸莫西沙星片 - NMPA 批准文号 | MedPath